News Quantified

MNKD – mannkind corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

MannKind Shares FUROSCIX® Business Updates [Yahoo! Finance]

MannKind Shares FUROSCIX® Business Updates

Reassessing MannKind (MNKD) Valuation After Recent Share Price Reset [Yahoo! Finance]

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease

MannKind (NASDAQ:MNKD) was given a new $9.00 price target on by analysts at Truist Financial Corporation.

7.1%

BEAT

-13.4%

BEAT

-2.7%

BEAT

-4.4%

BEAT

Leerink Partners

Form 4 MANNKIND CORP For: Dec 17 Filed by: Castagna Michael

Form 4 MANNKIND CORP For: Dec 12 Filed by: Castagna Michael

Form 8-K/A MANNKIND CORP For: Oct 07

Form 144 MANNKIND CORP Filed by: Castagna Michael

Form 4 MANNKIND CORP For: Dec 02 Filed by: Castagna Michael

Top News Gainers

4/10 Form DEFA14A MANNKIND CORP 11.5%

1/20 3 Top-Notch “Strong Buy” Stocks Under $3 [Yahoo! Finance News] 11.4%

9/11 MannKind: Investor Conference And Scripts - The Story Is Evolving [Seeking Alpha] 10.8%

1/10 MannKind Co. (NASDAQ: MNKD) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 7.3%

5/29 5 Years Since MannKind Received FDA Approval For Afrezza Doubts Swirl [Seeking Alpha] 5.3%

1/7 MannKind Co. (NASDAQ: MNKD) had its "outperform" rating re-affirmed by analysts at Svb Leerink Llc. 4.5%

7/31 Form 4 MANNKIND CORP For: Jul 31 Filed by: Barton Courtney 4.5%

2/20 MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020) 4.1%

9/9 MannKind Corporation (MNKD) presents at H.C. Wainwright 21st Annual Global Investment Conference (Transcript) [Seeking Alpha] 4.1%

5/14 MannKind Co. (NASDAQ: MNKD) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock. 3.9%

Top News Decliners

3/17 MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic -15.3%

2/25 Form 10-K MANNKIND CORP For: Dec 31 -14.6%

11/6 Q3/2019 9/30/2019 EPS -0.050 ZacksConsensus -0.070 ActVsEst 0.020 - Beat -11.4%

8/7 MannKind Corporation 2019 Q2 - Results - Earnings Call Slides [Seeking Alpha] -10.8%

5/7 Form 10-Q MANNKIND CORP For: Mar 31 -9.9%

1/27 MannKind Co. (NASDAQ: MNKD) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. -9.5%

1/22 Should You Worry About MannKind Corporation's (NASDAQ:MNKD) CEO Pay? [Yahoo! Finance News] -8.9%

5/16 Form 4 MANNKIND CORP For: May 14 Filed by: Tross Stuart A -7.3%

4/30 MannKind Co. (NASDAQ: MNKD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.50 price target on the stock. -7.1%

1/28 MannKind Co. (NASDAQ: MNKD) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -6.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day